114 related articles for article (PubMed ID: 6379653)
1. Muramyl dipeptide-induced enhancement of phagocytosis of antibiotic pretreated Escherichia coli by macrophages.
Friedman H; Warren G
Proc Soc Exp Biol Med; 1984 Sep; 176(4):366-70. PubMed ID: 6379653
[TBL] [Abstract][Full Text] [Related]
2. Muramyl dipeptide enhances in vitro peritoneal macrophage phagocytic activity.
McCoy DM; Brown GL; Ausobsky JR; Polk HC
Am Surg; 1985 Nov; 51(11):634-6. PubMed ID: 4062058
[TBL] [Abstract][Full Text] [Related]
3. Increased phagocytosis of Escherichia coli pretreated with subinhibitory concentrations of cyclacillin or ampicillin.
Friedman H; Warren GH
Proc Soc Exp Biol Med; 1982 Feb; 169(2):301-5. PubMed ID: 7038695
[No Abstract] [Full Text] [Related]
4. Lipophilic muramyl dipeptide-induced changes in electron microscopic morphology and phagocytic function of murine macrophages.
Masihi KN; Ozel M; Lange W; Azuma I
J Biol Response Mod; 1986 Feb; 5(1):20-6. PubMed ID: 3958752
[TBL] [Abstract][Full Text] [Related]
5. Cyclacillin-induced potentiation of Escherichia coli immunogenicity in vivo and in vitro.
Friedman H; Warren GH
Chemotherapy; 1977; 23(5):324-36. PubMed ID: 332464
[TBL] [Abstract][Full Text] [Related]
6. Macrophage activation through phagocytosis of muramyl dipeptide encapsulated in gelatin microspheres.
Tabata Y; Ikada Y
J Pharm Pharmacol; 1987 Sep; 39(9):698-704. PubMed ID: 2890735
[TBL] [Abstract][Full Text] [Related]
7. Effect of free or liposome-encapsulated muramyl dipeptide on uptake and intracellular survival of Listeria monocytogenes in mouse peritoneal macrophages in vitro.
Bakker-Woudenberg IA; Lokerse AF; Vink-van den Berg JC; Roerdink FH
Eur J Clin Microbiol Infect Dis; 1989 Jul; 8(7):603-9. PubMed ID: 2506020
[TBL] [Abstract][Full Text] [Related]
8. Activation of macrophages for enhanced release of superoxide anion and greater killing of Candida albicans by injection of muramyl dipeptide.
Cummings NP; Pabst MJ; Johnston RB
J Exp Med; 1980 Dec; 152(6):1659-69. PubMed ID: 6256464
[TBL] [Abstract][Full Text] [Related]
9. Effects of muramyl dipeptide and lead acetate on carbon clearance and endotoxin-induced mortality in mice.
Cheadle WG; Ausobsky JR; Trachtenberg LS; Lamont P; Polk HC
Am Surg; 1986 Nov; 52(11):613-7. PubMed ID: 3535600
[TBL] [Abstract][Full Text] [Related]
10. The nucleotide-binding oligomerization domain-containing-2 ligand muramyl dipeptide enhances phagocytosis and intracellular killing of Escherichia coli K1 by Toll-like receptor agonists in microglial cells.
Ribes S; Adam N; Schütze S; Regen T; Redlich S; Janova H; Borisch A; Hanisch UK; Nau R
J Neuroimmunol; 2012 Nov; 252(1-2):16-23. PubMed ID: 22889567
[TBL] [Abstract][Full Text] [Related]
11. Effect of dihydrostreptomycin on phagocytosis of mouse-peritoneal macrophages in vitro.
Adam D; Staber F; Belohradsky BH; Marget W
Infect Immun; 1972 Apr; 5(4):537-41. PubMed ID: 4117984
[TBL] [Abstract][Full Text] [Related]
12. Non-specific host defence stimulation and antibiotic-resistant infection.
Lamont PM; Trachtenberg LS; West CS; Polk HC
J Antimicrob Chemother; 1983 Oct; 12 Suppl C():117-22. PubMed ID: 6358180
[TBL] [Abstract][Full Text] [Related]
13. Macrophages are stimulated by muramyl dipeptide to induce polymorphonuclear leukocyte accumulation in the peritoneal cavities of guinea pigs.
Nagao S; Nakanishi M; Kutsukake H; Yagawa K; Kusumoto S; Shiba T; Tanaka A; Kotani S
Infect Immun; 1990 Feb; 58(2):536-42. PubMed ID: 2298491
[TBL] [Abstract][Full Text] [Related]
14. Effect of N-acetyl-muramyl-L-alanyl-D-isoglutamine on interferon production in mice by Newcastle disease virus.
Sakuma T; Azuma M; Yoshida I
J Gen Virol; 1984 May; 65 ( Pt 5)():999-1003. PubMed ID: 6202835
[TBL] [Abstract][Full Text] [Related]
15. Oxidative metabolic response and microbicidal activity of human milk macrophages: effect of lipopolysaccharide and muramyl dipeptide.
Cummings NP; Neifert MR; Pabst MJ; Johnston RB
Infect Immun; 1985 Aug; 49(2):435-9. PubMed ID: 2991139
[TBL] [Abstract][Full Text] [Related]
16. Age-dependent effects of aminobutyryl muramyl dipeptide on alveolar macrophage function in infant and adult Macaca monkeys.
Jacobs RF; Wilson CB; Smith AL; Haas JE
Am Rev Respir Dis; 1983 Nov; 128(5):862-7. PubMed ID: 6638675
[TBL] [Abstract][Full Text] [Related]
17. MDP(Lysyl)GDP, a nontoxic muramyl dipeptide derivative, inhibits cytokine production by activated macrophages and protects mice from phorbol ester- and oxazolone-induced inflammation.
Zunic M; Bahr GM; Mudde GC; Meingassner JG; Lam C
J Invest Dermatol; 1998 Jul; 111(1):77-82. PubMed ID: 9665390
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of Fc receptor expression in guinea pig peritoneal exudate macrophages by muramyl dipeptide or lipopolysaccharide.
Yagawa K; Kaku M; Ichinose Y; Nagao S; Tanaka A; Aida Y; Tomoda A
J Immunol; 1985 Jun; 134(6):3705-11. PubMed ID: 2985692
[TBL] [Abstract][Full Text] [Related]
19. Macrophage activation for antitumour function by muramyl dipeptide-protein conjugates.
Tabata Y; Ikada Y
J Pharm Pharmacol; 1990 Jan; 42(1):13-9. PubMed ID: 1969943
[TBL] [Abstract][Full Text] [Related]
20. Muramyl dipeptide increases tolerance to shock and bacterial challenge in mice.
Ausobsky JR; Cheadle WG; Brosky BG; Polk HC
Br J Surg; 1984 Feb; 71(2):151-3. PubMed ID: 6362769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
